v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 50,612 $ 47,268 $ 38,079
Reconciliations of net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 7,110 6,228 5,326
Non-cash operating lease expense 7,036 6,955 8,045
Investment amortization and losses recognized 1,396 1,859 1,433
Loss recognized on disposal of property and equipment 256 139 114
Deferred income taxes 4,626 (2,169) (347)
Share-based compensation 8,465 7,390 5,366
Changes in certain operating assets and liabilities:      
Trade accounts receivable (7,569) (8,131) (37,201)
Income taxes (8,597) (1,063) 8,158
Prepaid expenses and other 1,344 (2,181) (1,645)
Accounts payable (1,671) 3,779 (261)
Accrued payroll, payroll taxes and related benefits 12,728 24,916 49,739
Other accrued liabilities (3,390) 3,644 25
Premium payable 54,168 12,081 7,728
Workers' compensation claims liabilities (51,246) (64,222) (77,640)
Safety incentives liability (787) (2,273) (14,505)
Operating lease liabilities (7,099) (6,740) (7,886)
Other assets and liabilities, net (160) 298 13
Net cash provided by (used in) operating activities 67,222 27,778 (15,459)
Cash flows from investing activities:      
Purchase of property, equipment and software (11,827) (15,973) (6,801)
Proceeds from sale of property 120    
Purchase of investments (4,387)   (54,835)
Proceeds from sales and maturities of investments 10,352 18,732 75,256
Purchase of restricted investments (66,734) (4,345) (253,781)
Proceeds from sales and maturities of restricted investments 17,289 62,740 127,298
Net cash provided by (used in) investing activities (55,187) 61,154 (112,863)
Cash flows from financing activities:      
Proceeds from credit-line borrowings 12,313   2,718
Payments on credit-line borrowings (12,313)   (2,718)
Payments on long-term debt   (3,510) (221)
Repurchase of common stock (34,192) (47,168) (17,287)
Common stock repurchased on vesting of stock awards (2,993) (1,692) (1,465)
Dividends paid (8,089) (8,524) (9,069)
Proceeds from exercise of stock options and purchase of ESPP 702 711 1,156
Net cash used in financing activities (44,572) (60,183) (26,886)
Net increase (decrease) in cash, cash equivalents and restricted cash (32,537) 28,749 (155,208)
Cash, cash equivalents and restricted cash, beginning of period 107,378 78,629 233,837
Cash, cash equivalents and restricted cash, end of period $ 74,841 $ 107,378 $ 78,629

Source